Skip to main content
. 2021 Jul 26;11:693234. doi: 10.3389/fonc.2021.693234

Figure 2.

Figure 2

Relationship between TLS signature and tumor immune microenvironment. (A) Differences in immune cell subsets between the TLS signature high (n = 337) and low (n = 169) groups; (B) Differences in cancer immune circulation between the TLS signature high (n = 337) and low groups (n = 169); (C) Differences in the expression of checkpoint genes between the TLS signature high (n = 337) and low groups (n = 169). Wilcoxon text, ****P < 0.0001; ns, not significant.